Integrity Alliance LLC. Purchases 699,023 Shares of Stereotaxis Inc. $STXS

Integrity Alliance LLC. bought a new stake in Stereotaxis Inc. (NYSEAMERICAN:STXS) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 699,023 shares of the company’s stock, valued at approximately $860,000. Integrity Alliance LLC. owned 0.70% of Stereotaxis as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently made changes to their positions in the company. Bank of New York Mellon Corp bought a new position in shares of Stereotaxis in the second quarter valued at $364,000. Sei Investments Co. grew its holdings in Stereotaxis by 108.9% during the 1st quarter. Sei Investments Co. now owns 518,884 shares of the company’s stock worth $955,000 after acquiring an additional 270,443 shares during the period. Finally, Sequoia Financial Advisors LLC acquired a new stake in shares of Stereotaxis in the 1st quarter valued at about $700,000. Institutional investors own 45.35% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on STXS. Citizens Jmp decreased their price target on shares of Stereotaxis from $4.00 to $3.00 and set a “market outperform” rating on the stock in a report on Thursday, August 27th. Citigroup reiterated an “outperform” rating on shares of Stereotaxis in a report on Thursday, August 27th. Finally, TD Cowen cut their target price on shares of Stereotaxis from $5.00 to $3.00 and set a “buy” rating for the company in a report on Wednesday, August 12th. Five equities research analysts have rated the stock with a Buy rating. According to MarketBeat.com, Stereotaxis presently has an average rating of “Buy” and an average target price of $3.38.

Stereotaxis Trading Up 3.8%

Shares of NYSEAMERICAN STXS opened at $1.09 on Friday. The stock has a 50 day simple moving average of $1.17 and a 200-day simple moving average of $1.67. The company has a market cap of $109.22 million, a PE ratio of -4.54 and a beta of 1.40. Stereotaxis Inc. has a 12-month low of $0.80 and a 12-month high of $2.89.

Stereotaxis (NYSEAMERICAN:STXS) last posted its earnings results on Tuesday, August 11th. The company reported ($0.05) earnings per share for the quarter, meeting the consensus estimate of ($0.05). Stereotaxis had a negative return on equity of 130.84% and a negative net margin of 74.24%. The company had revenue of $7.67 million for the quarter, compared to analyst estimates of $8.35 million. Sell-side analysts forecast that Stereotaxis Inc. will post -0.22 earnings per share for the current fiscal year.

About Stereotaxis

Stereotaxis, Inc develops robotic technologies for minimally invasive endovascular procedures, with a primary focus on cardiac electrophysiology. Its systems use magnetic navigation and specialized software to help physicians control guidewires and catheters during procedures such as the treatment of cardiac arrhythmias.

The company’s product portfolio includes the Genesis Robotic Magnetic Navigation System, which is designed to provide precise catheter movement and navigation within the heart.